KRTAP10-13P

Across TCGA pan-cancer cohorts, KRTAP10-13P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated KRTAP10-13P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher KRTAP10-13P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRTAP10-13P expression acts as an unfavorable survival marker, although some lineages such as PAAD show a favorable association.

ACC, HNSC, and KIRC are the cancer types where KRTAP10-13P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.667	<.001	135	view →
HNSC	DFS	Tertile	II,III,IV	0.333	0.631	<.001	96	view →
KIRC	DFS	Tertile	All	0.258	0.642	.004	42	view →
PAAD	DFS	Tertile	All	0.852	0.254	.004	33	view →
SKCM	OS	Tertile	II,III,IV	0.106	0.323	.006	24	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

KRTAP10-13P–ACC (DFS)

Open the ACC breakdown →